Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2025
The global interventional cardiology devices marketsize is projected to reach USD 21.2billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9% during the forecast period. The rapid growth in the geriatric population and the associated increase in the prevalence of interventional cardiology diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries are driving the growth of the interventional cardiology devices.
“Thrombectomy devicesaccountedfor the larger share of theplaque modification devices market in 2019.”
Based on type, the plaque modification devices market is segmented into atherectomy and thrombectomy. In 2019, the thrombectomy devices segment accounted for the larger market share, mainly due to the increasing incidence of blood clots andaortic embolisms across the globe.
“Embolic protection devicesaccounted for the largest share of thehemodynamic flow altration devices market in 2019.”
Based on type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices. In 2019, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market. This can be attributed to the advantages of EPDs over CTO devices, such as the ability to capture embolic debris without interrupting continuous blood flow.
“Asia Pacific estimated to register the highest CAGRduring the forecast period.”
In this report, the interventional cardiology devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific isprojected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of aging population, increasing prevalence of diabetes, and rising focus of key players in this region.
Breakdown of primary supply-side interviews, by company type, designation, and region:
1. Medtronic (Ireland)
2. Boston Scientific Corporation (US)
3. B. Braun Melsungen AG(Germany)
4. Abbott (US)
5. Cardinal Health (US)
6. Edward Lifesciences Corporation(US)
7. Penumbra, Inc. (US)
8. Terumo Corporation (Japan)
9. Alvimedica (Turkey)
10. ENDOCOR GmbH (Germany)
11. Biosensor International (Singapore)
12. Koninklijke Philips N.V. (Netherlands)
13. AMG International GmbH (Germany)
14. iVascular (Spain)
15. SMT (India)
16. Meril Life Sciences Pvt Ltd. (India)
17. Medinol (Israel)
18. InSitu Technologies, Inc. (US)
19. Andramed GmbH (Germany)
20. Cardionovum GmbH (Germany)
21. Wellinq (Netherlands)
22. SCITECH (Brazil)
23. Comed B.V (Netherlands)
24. BALTON Sp. z o.o (Poland)
25. Rontis (Switzerland)
26. STENTYS S.A. (France)
Research Coverage
This report studies the interventional cardiology devices market based on product and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarketswith respect to their growth trends, prospects, and contributions to the total interventional cardiology devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
“Thrombectomy devicesaccountedfor the larger share of theplaque modification devices market in 2019.”
Based on type, the plaque modification devices market is segmented into atherectomy and thrombectomy. In 2019, the thrombectomy devices segment accounted for the larger market share, mainly due to the increasing incidence of blood clots andaortic embolisms across the globe.
“Embolic protection devicesaccounted for the largest share of thehemodynamic flow altration devices market in 2019.”
Based on type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices. In 2019, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market. This can be attributed to the advantages of EPDs over CTO devices, such as the ability to capture embolic debris without interrupting continuous blood flow.
“Asia Pacific estimated to register the highest CAGRduring the forecast period.”
In this report, the interventional cardiology devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific isprojected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of aging population, increasing prevalence of diabetes, and rising focus of key players in this region.
Breakdown of primary supply-side interviews, by company type, designation, and region:
- By Company Type: Tier 1 (70%) , Tier 2 (20%), and Tier 3 (10%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), AsiaPacific (25%), and Rest of the World(16%)
1. Medtronic (Ireland)
2. Boston Scientific Corporation (US)
3. B. Braun Melsungen AG(Germany)
4. Abbott (US)
5. Cardinal Health (US)
6. Edward Lifesciences Corporation(US)
7. Penumbra, Inc. (US)
8. Terumo Corporation (Japan)
9. Alvimedica (Turkey)
10. ENDOCOR GmbH (Germany)
11. Biosensor International (Singapore)
12. Koninklijke Philips N.V. (Netherlands)
13. AMG International GmbH (Germany)
14. iVascular (Spain)
15. SMT (India)
16. Meril Life Sciences Pvt Ltd. (India)
17. Medinol (Israel)
18. InSitu Technologies, Inc. (US)
19. Andramed GmbH (Germany)
20. Cardionovum GmbH (Germany)
21. Wellinq (Netherlands)
22. SCITECH (Brazil)
23. Comed B.V (Netherlands)
24. BALTON Sp. z o.o (Poland)
25. Rontis (Switzerland)
26. STENTYS S.A. (France)
Research Coverage
This report studies the interventional cardiology devices market based on product and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarketswith respect to their growth trends, prospects, and contributions to the total interventional cardiology devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the interventional cardiology devices offered by the top 10 players in the market. The report analyzes the interventional cardiology devices market by product and region
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various interventional cardiology devices across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional cardiology devices market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the interventional cardiology devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Bottom-up approach for the interventional cardiology devices market
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 14 GEOGRAPHIC SNAPSHOT OF THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
4 PREMIUM INSIGHTS
4.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET OVERVIEW
FIGURE 15 INCREASING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE GROWTH IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
4.2 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 16 DRUG-ELUTING STENTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
4.3 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY CATHETER TYPE AND COUNTRY
FIGURE 17 THE US IS EXPECTED TO DOMINATE THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET IN 2020
4.4 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of coronary artery disease
FIGURE 20 GLOBAL INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2030 VS. 2045
5.2.1.2 Rising tobacco consumption and increasing incidence of obesity
5.2.1.3 Favorable reimbursements for interventional cardiology procedures
TABLE 1 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES IN THE US
5.2.2 RESTRAINTS
5.2.2.1 Availability of alternative treatments
5.2.2.2 Low affordability and inaccessibility of cardiac surgeries in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential of emerging economies
5.2.3.2 Increasing number of product approvals
TABLE 2 RECENT APPROVALS OF VARIOUS TYPES OF INTERVENTIONAL CARDIOLOGY DEVICES, 2018–2020
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory requirements delaying the approval of cardiac devices
5.2.4.2 Product failures and recalls
5.3 COVID-19 IMPACT ON THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
5.4 PRICING ANALYSIS
TABLE 3 INTERVENTIONAL CARDIOLOGY DEVICES, AVERAGE SELLING PRICES (USD)
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.7 ECOSYSTEM ANALYSIS
5.8 TECHNOLOGY ANALYSIS
5.9 REGULATORY LANDSCAPE
5.10 PESTLE ANALYSIS
6 ANGIOPLASTY STENTS MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 4 ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.1.1 DRUG-ELUTING STENTS
6.1.1.1 Drug-eluting stents hold the largest share of the angioplasty stents market
TABLE 5 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
6.1.2 BARE-METAL STENTS
6.1.2.1 Increasing use of drug-eluting stents has limited the growth of the bare-metal stents market
TABLE 7 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
6.1.3 BIOABSORBABLE STENTS
6.1.3.1 Bioabsorbable stents ensure the complete healing of the arteries—a key factor driving market growth
TABLE 9 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
7 STRUCTURAL HEART DEVICES MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 11 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.1.1 AORTIC VALVE THERAPY DEVICES
7.1.1.1 Increasing prevalence of aortic valve stenosis to support the market growth
TABLE 12 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
7.1.2 OTHER THERAPY DEVICES
TABLE 14 OTHER THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
8 CATHETERS MARKET, BY TYPE
8.1 INTRODUCTION
TABLE 15 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
8.1.1 ANGIOGRAPHY CATHETERS
8.1.1.1 Angiography catheters hold the largest share of the catheters market during the forecast period
TABLE 16 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.1.2 GUIDING CATHETERS
8.1.2.1 Guiding catheters to account for the second-largest share of the catheters market during the forecast period
TABLE 17 GUIDING CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.1.3 IVUS/OCT CATHETERS
8.1.3.1 IVUS/OCT catheters to register the highest growth rate during the forecast period
TABLE 18 IVUS/OCT CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
9 ANGIOPLASTY BALLOONS MARKET, BY TYPE
9.1 INTRODUCTION
TABLE 19 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.1.1 OLD/NORMAL BALLOONS
9.1.1.1 Low treatment costs associated with this technique to drive the growth of the old/normal balloons market
TABLE 20 OLD/NORMAL BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.1.2 DRUG-ELUTING BALLOONS
9.1.2.1 Rising number of regulatory approvals for drug-eluting balloons to drive market growth during the forecast period
TABLE 21 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.1.3 CUTTING/SCORING BALLOONS
9.1.3.1 Use of cutting balloon-aided procedures is very limited since medication is the primary treatment for atherosclerosis
TABLE 22 CUTTING/SCORING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
10 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE
10.1 INTRODUCTION
TABLE 23 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.1.1 THROMBECTOMY DEVICES
10.1.1.1 Thrombectomy devices segment dominates the plaque modification devices market
TABLE 24 THROMBECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
10.1.2 ATHERECTOMY DEVICES
10.1.2.1 Growing use of lipid-modifying drugs for the treatment of atherosclerosis instead of atherectomy devices to limit market growth
TABLE 25 ATHERECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE
11.1 INTRODUCTION
TABLE 26 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
11.1.1 EMBOLIC PROTECTION DEVICES
11.1.1.1 Embolic protection devices to dominate the hemodynamic flow alteration devices market during the forecast period
TABLE 27 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
11.1.2 CHRONIC TOTAL OCCLUSION DEVICES
11.1.2.1 CTO devices market has witnessed tremendous innovations, thereby expanding the options available for physicians
TABLE 28 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE
12.1 INTRODUCTION
TABLE 29 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.1.1 GUIDEWIRES
TABLE 30 GUIDEWIRES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.2 VASCULAR CLOSURE DEVICES
TABLE 31 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.3 INTRODUCER SHEATHS
TABLE 32 INTRODUCER SHEATHS MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.4 BALLOON INFLATION DEVICES
TABLE 33 BALLOON INFLATION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.5 HEMOSTASIS HEART VALVES
TABLE 34 HEMOSTASIS HEART VALVES MARKET, BY REGION, 2018–2025 (USD MILLION)
13 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION
13.1 INTRODUCTION
TABLE 35 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
13.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
TABLE 36 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.2.1 US
13.2.1.1 Availability of reimbursements for interventional cardiology procedures to support the market growth
TABLE 44 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
TABLE 45 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 US: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 US: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.2.2 CANADA
13.2.2.1 Rising incidence of target diseases to support the market growth
TABLE 52 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 CANADA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 CANADA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3 EUROPE
TABLE 59 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.1 GERMANY
13.3.1.1 Germany holds the largest share of the European interventional cardiology devices market
TABLE 67 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 68 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 GERMANY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 GERMANY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.2 FRANCE
13.3.2.1 Favorable government initiatives in France to support the growth of the interventional cardiology devices market in the country
TABLE 74 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 FRANCE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 79 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 FRANCE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.3 UK
13.3.3.1 High burden of target diseases to drive the market in the country
TABLE 81 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 UK: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.4 SPAIN
13.3.4.1 Growing geriatric population to increase the demand for interventional cardiology devices in the country
TABLE 88 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 SPAIN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 SPAIN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.5 ITALY
13.3.5.1 Rising levels of obesity to increase the demand for interventional cardiology devices in the country
TABLE 95 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 ITALY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.6 REST OF EUROPE
TABLE 102 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017
TABLE 103 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 ROE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 ROE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.1 JAPAN
13.4.1.1 Japan dominates the Asia Pacific interventional cardiology devices market
TABLE 118 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 JAPAN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 JAPAN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.2 CHINA
13.4.2.1 Highest tobacco consumption in the world—a major factor driving market growth in China
TABLE 125 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 CHINA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.3 INDIA
13.4.3.1 Increasing target patient population to drive the market in the country
TABLE 132 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 INDIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 INDIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.4 AUSTRALIA
13.4.4.1 Increasing prevalence of heart diseases to support the market growth
TABLE 139 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.5 REST OF ASIA PACIFIC
TABLE 146 ROAPAC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 ROAPAC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 ROAPAC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 ROAPAC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 ROAPAC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 ROAPAC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 ROAPAC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5 REST OF THE WORLD
TABLE 153 ROW: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 154 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 ROW: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 ROW: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 ROW: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5.1 LATIN AMERICA
13.5.1.1 Latin America dominates the RoW interventional cardiology devices market
TABLE 161 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5.2 MIDDLE EAST & AFRICA
13.5.2.1 Increasing prevalence of diabetes to support market growth in the Middle East & Africa
TABLE 168 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET, JANUARY 2017–NOVEMBER 2020
FIGURE 26 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO NOVEMBER 2020
14.2 COMPETITIVE SCENARIO
14.2.1 AGREEMENTS & PARTNERSHIPS
TABLE 175 KEY AGREEMENTS & PARTNERSHIPS
14.2.2 PRODUCT LAUNCHES & APPROVALS
TABLE 176 KEY PRODUCT LAUNCHES & APPROVALS
14.2.3 EXPANSIONS
TABLE 177 KEY EXPANSIONS
14.2.4 ACQUISITIONS
TABLE 178 KEY ACQUISITIONS
14.2.5 OTHER DEVELOPMENTS
TABLE 179 OTHER DEVELOPMENTS
14.3 MARKET SHARE ANALYSIS, 2019
FIGURE 27 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE ANALYSIS, 2019
14.4 COMPANY EVALUATION MATRIX
14.4.1 STARS
14.4.2 EMERGING LEADERS
14.4.3 PERVASIVE PLAYERS
14.4.4 PARTICIPANTS
FIGURE 28 VENDOR DIVE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
14.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS/SMES)
14.5.1 PROGRESSIVE COMPANIES
14.5.2 STARTING BLOCKS
14.5.3 RESPONSIVE COMPANIES
14.5.4 DYNAMIC COMPANIES
FIGURE 29 VENDOR DIVE MATRIX FOR START-UPS: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
15 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
15.1 BOSTON SCIENTIFIC CORPORATION
FIGURE 30 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
15.2 MEDTRONIC PLC
FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
15.3 ABBOTT LABORATORIES
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
15.4 EDWARDS LIFESCIENCES CORPORATION
FIGURE 33 EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2019)
15.5 TERUMO CORPORATION
FIGURE 34 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
15.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
FIGURE 35 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2019)
15.7 B. BRAUN MELSUNGEN AG
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
15.8 KONINKLIJKE PHILIPS N.V.
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
15.9 IVASCULAR S.L.U.
15.10 BIOSENSORS INTERNATIONAL
15.11 BIOTRONIK SE & CO. KG
15.12 PENUMBRA, INC.
FIGURE 38 PENUMBRA, INC: COMPANY SNAPSHOT (2019)
15.13 AMG INTERNATIONAL (A SUBSIDIARY OF Q3 MEDICAL)
15.14 ENDOCOR GMBH
15.15 INSITU TECHNOLOGIES, INC.
15.16 MERIL LIFE SCIENCES PVT. LTD.
15.17 ALVIMEDICA
15.18 CARDIONOVUM GMBH
15.19 SMT
15.20 MEDINOL LTD.
15.21 WELLINQ
15.22 SCITECH
15.23 COMED B.V. (A SUBSIDIARY OF LEPU MEDICAL TECHNOLOGY HOLDING)
15.24 BALTON SP. Z O.O
15.25 RONTIS
15.26 STENTYS SA
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
16 APPENDIX
16.1 INSIGHTS FROM INDUSTRY EXPERTS
16.2 DISCUSSION GUIDE
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4 AVAILABLE CUSTOMIZATIONS
16.5 RELATED REPORTS
16.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Bottom-up approach for the interventional cardiology devices market
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 14 GEOGRAPHIC SNAPSHOT OF THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
4 PREMIUM INSIGHTS
4.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET OVERVIEW
FIGURE 15 INCREASING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE GROWTH IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
4.2 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 16 DRUG-ELUTING STENTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
4.3 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY CATHETER TYPE AND COUNTRY
FIGURE 17 THE US IS EXPECTED TO DOMINATE THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET IN 2020
4.4 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of coronary artery disease
FIGURE 20 GLOBAL INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2030 VS. 2045
5.2.1.2 Rising tobacco consumption and increasing incidence of obesity
5.2.1.3 Favorable reimbursements for interventional cardiology procedures
TABLE 1 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES IN THE US
5.2.2 RESTRAINTS
5.2.2.1 Availability of alternative treatments
5.2.2.2 Low affordability and inaccessibility of cardiac surgeries in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential of emerging economies
5.2.3.2 Increasing number of product approvals
TABLE 2 RECENT APPROVALS OF VARIOUS TYPES OF INTERVENTIONAL CARDIOLOGY DEVICES, 2018–2020
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory requirements delaying the approval of cardiac devices
5.2.4.2 Product failures and recalls
5.3 COVID-19 IMPACT ON THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
5.4 PRICING ANALYSIS
TABLE 3 INTERVENTIONAL CARDIOLOGY DEVICES, AVERAGE SELLING PRICES (USD)
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.7 ECOSYSTEM ANALYSIS
5.8 TECHNOLOGY ANALYSIS
5.9 REGULATORY LANDSCAPE
5.10 PESTLE ANALYSIS
6 ANGIOPLASTY STENTS MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 4 ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.1.1 DRUG-ELUTING STENTS
6.1.1.1 Drug-eluting stents hold the largest share of the angioplasty stents market
TABLE 5 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
6.1.2 BARE-METAL STENTS
6.1.2.1 Increasing use of drug-eluting stents has limited the growth of the bare-metal stents market
TABLE 7 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
6.1.3 BIOABSORBABLE STENTS
6.1.3.1 Bioabsorbable stents ensure the complete healing of the arteries—a key factor driving market growth
TABLE 9 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
7 STRUCTURAL HEART DEVICES MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 11 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.1.1 AORTIC VALVE THERAPY DEVICES
7.1.1.1 Increasing prevalence of aortic valve stenosis to support the market growth
TABLE 12 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
7.1.2 OTHER THERAPY DEVICES
TABLE 14 OTHER THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
8 CATHETERS MARKET, BY TYPE
8.1 INTRODUCTION
TABLE 15 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
8.1.1 ANGIOGRAPHY CATHETERS
8.1.1.1 Angiography catheters hold the largest share of the catheters market during the forecast period
TABLE 16 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.1.2 GUIDING CATHETERS
8.1.2.1 Guiding catheters to account for the second-largest share of the catheters market during the forecast period
TABLE 17 GUIDING CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.1.3 IVUS/OCT CATHETERS
8.1.3.1 IVUS/OCT catheters to register the highest growth rate during the forecast period
TABLE 18 IVUS/OCT CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
9 ANGIOPLASTY BALLOONS MARKET, BY TYPE
9.1 INTRODUCTION
TABLE 19 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.1.1 OLD/NORMAL BALLOONS
9.1.1.1 Low treatment costs associated with this technique to drive the growth of the old/normal balloons market
TABLE 20 OLD/NORMAL BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.1.2 DRUG-ELUTING BALLOONS
9.1.2.1 Rising number of regulatory approvals for drug-eluting balloons to drive market growth during the forecast period
TABLE 21 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.1.3 CUTTING/SCORING BALLOONS
9.1.3.1 Use of cutting balloon-aided procedures is very limited since medication is the primary treatment for atherosclerosis
TABLE 22 CUTTING/SCORING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
10 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE
10.1 INTRODUCTION
TABLE 23 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.1.1 THROMBECTOMY DEVICES
10.1.1.1 Thrombectomy devices segment dominates the plaque modification devices market
TABLE 24 THROMBECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
10.1.2 ATHERECTOMY DEVICES
10.1.2.1 Growing use of lipid-modifying drugs for the treatment of atherosclerosis instead of atherectomy devices to limit market growth
TABLE 25 ATHERECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE
11.1 INTRODUCTION
TABLE 26 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
11.1.1 EMBOLIC PROTECTION DEVICES
11.1.1.1 Embolic protection devices to dominate the hemodynamic flow alteration devices market during the forecast period
TABLE 27 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
11.1.2 CHRONIC TOTAL OCCLUSION DEVICES
11.1.2.1 CTO devices market has witnessed tremendous innovations, thereby expanding the options available for physicians
TABLE 28 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE
12.1 INTRODUCTION
TABLE 29 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.1.1 GUIDEWIRES
TABLE 30 GUIDEWIRES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.2 VASCULAR CLOSURE DEVICES
TABLE 31 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.3 INTRODUCER SHEATHS
TABLE 32 INTRODUCER SHEATHS MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.4 BALLOON INFLATION DEVICES
TABLE 33 BALLOON INFLATION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.5 HEMOSTASIS HEART VALVES
TABLE 34 HEMOSTASIS HEART VALVES MARKET, BY REGION, 2018–2025 (USD MILLION)
13 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION
13.1 INTRODUCTION
TABLE 35 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
13.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
TABLE 36 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.2.1 US
13.2.1.1 Availability of reimbursements for interventional cardiology procedures to support the market growth
TABLE 44 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
TABLE 45 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 US: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 US: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.2.2 CANADA
13.2.2.1 Rising incidence of target diseases to support the market growth
TABLE 52 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 CANADA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 CANADA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3 EUROPE
TABLE 59 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.1 GERMANY
13.3.1.1 Germany holds the largest share of the European interventional cardiology devices market
TABLE 67 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 68 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 GERMANY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 GERMANY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.2 FRANCE
13.3.2.1 Favorable government initiatives in France to support the growth of the interventional cardiology devices market in the country
TABLE 74 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 FRANCE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 79 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 FRANCE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.3 UK
13.3.3.1 High burden of target diseases to drive the market in the country
TABLE 81 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 UK: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.4 SPAIN
13.3.4.1 Growing geriatric population to increase the demand for interventional cardiology devices in the country
TABLE 88 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 SPAIN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 SPAIN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.5 ITALY
13.3.5.1 Rising levels of obesity to increase the demand for interventional cardiology devices in the country
TABLE 95 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 ITALY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.6 REST OF EUROPE
TABLE 102 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017
TABLE 103 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 ROE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 ROE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.1 JAPAN
13.4.1.1 Japan dominates the Asia Pacific interventional cardiology devices market
TABLE 118 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 JAPAN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 JAPAN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.2 CHINA
13.4.2.1 Highest tobacco consumption in the world—a major factor driving market growth in China
TABLE 125 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 CHINA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.3 INDIA
13.4.3.1 Increasing target patient population to drive the market in the country
TABLE 132 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 INDIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 INDIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.4 AUSTRALIA
13.4.4.1 Increasing prevalence of heart diseases to support the market growth
TABLE 139 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.5 REST OF ASIA PACIFIC
TABLE 146 ROAPAC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 ROAPAC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 ROAPAC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 ROAPAC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 ROAPAC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 ROAPAC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 ROAPAC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5 REST OF THE WORLD
TABLE 153 ROW: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 154 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 ROW: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 ROW: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 ROW: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5.1 LATIN AMERICA
13.5.1.1 Latin America dominates the RoW interventional cardiology devices market
TABLE 161 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5.2 MIDDLE EAST & AFRICA
13.5.2.1 Increasing prevalence of diabetes to support market growth in the Middle East & Africa
TABLE 168 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET, JANUARY 2017–NOVEMBER 2020
FIGURE 26 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO NOVEMBER 2020
14.2 COMPETITIVE SCENARIO
14.2.1 AGREEMENTS & PARTNERSHIPS
TABLE 175 KEY AGREEMENTS & PARTNERSHIPS
14.2.2 PRODUCT LAUNCHES & APPROVALS
TABLE 176 KEY PRODUCT LAUNCHES & APPROVALS
14.2.3 EXPANSIONS
TABLE 177 KEY EXPANSIONS
14.2.4 ACQUISITIONS
TABLE 178 KEY ACQUISITIONS
14.2.5 OTHER DEVELOPMENTS
TABLE 179 OTHER DEVELOPMENTS
14.3 MARKET SHARE ANALYSIS, 2019
FIGURE 27 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE ANALYSIS, 2019
14.4 COMPANY EVALUATION MATRIX
14.4.1 STARS
14.4.2 EMERGING LEADERS
14.4.3 PERVASIVE PLAYERS
14.4.4 PARTICIPANTS
FIGURE 28 VENDOR DIVE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
14.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS/SMES)
14.5.1 PROGRESSIVE COMPANIES
14.5.2 STARTING BLOCKS
14.5.3 RESPONSIVE COMPANIES
14.5.4 DYNAMIC COMPANIES
FIGURE 29 VENDOR DIVE MATRIX FOR START-UPS: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
15 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
15.1 BOSTON SCIENTIFIC CORPORATION
FIGURE 30 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
15.2 MEDTRONIC PLC
FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
15.3 ABBOTT LABORATORIES
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
15.4 EDWARDS LIFESCIENCES CORPORATION
FIGURE 33 EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2019)
15.5 TERUMO CORPORATION
FIGURE 34 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
15.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
FIGURE 35 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2019)
15.7 B. BRAUN MELSUNGEN AG
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
15.8 KONINKLIJKE PHILIPS N.V.
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
15.9 IVASCULAR S.L.U.
15.10 BIOSENSORS INTERNATIONAL
15.11 BIOTRONIK SE & CO. KG
15.12 PENUMBRA, INC.
FIGURE 38 PENUMBRA, INC: COMPANY SNAPSHOT (2019)
15.13 AMG INTERNATIONAL (A SUBSIDIARY OF Q3 MEDICAL)
15.14 ENDOCOR GMBH
15.15 INSITU TECHNOLOGIES, INC.
15.16 MERIL LIFE SCIENCES PVT. LTD.
15.17 ALVIMEDICA
15.18 CARDIONOVUM GMBH
15.19 SMT
15.20 MEDINOL LTD.
15.21 WELLINQ
15.22 SCITECH
15.23 COMED B.V. (A SUBSIDIARY OF LEPU MEDICAL TECHNOLOGY HOLDING)
15.24 BALTON SP. Z O.O
15.25 RONTIS
15.26 STENTYS SA
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
16 APPENDIX
16.1 INSIGHTS FROM INDUSTRY EXPERTS
16.2 DISCUSSION GUIDE
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4 AVAILABLE CUSTOMIZATIONS
16.5 RELATED REPORTS
16.6 AUTHOR DETAILS
The report “Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019”.
It provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market along with the estimates and forecasts of the revenue and market share analysis.
The global interventional cardiology and peripheral vascular devices market is expected to reach $26.72 Billion by 2019 from $18.73 Billion in 2014, at a CAGR of 7.4% from 2014 to 2019.
Key players in Interventional Cardiology and Peripheral Vascular Devices Market are
- Abbott Laboratories (U.S.)
- Boston Scientific (U.S.)
- B. Braun Melsungen AG (Germany)
- Cordis Corporation (U.S.)
- C.R. Bard, Inc. (U.S.)
- Medtronic Inc. (U.S.)
- Terumo Corporation (Japan)
The report segments this market based on products that include angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Among various products, the angioplasty stents segment is expected to account for the largest share of the market. High growth in this segment can be attributed to the increasing company investments to develop new stents with better clinical outcomes.
Based on geography, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this geographic segment is driven by factors such as rising incidence of cardiovascular diseases, rising aging population base, and technological advancements.
